Literature DB >> 17641841

Construction of porcine CCK pDNA and its expression in COS-7 cells.

Jigang Bai1, Yi Lü, Qiaoling Bai.   

Abstract

CCK correlates with the generation and progression of pancreatic cancer. The research aims to construct eukaryotic expression plasmid pIRES2-EGFP/CCK (CCK pDNA) and transiently express it in COS-7 cells. Total RNA was extracted from porcine intestinal mucosa. RT-PCR was used to amplify the aimed segments CCKcDNA which was then digested with EcoR1 and BamH1 and inserted into a eukaryotic expression plasmid pIRES2-EGFP to construct CCK pDNA. The constructed plasmid was transfected into COS-7 cells by lepofectamin 2000-mediated transfer method. The expression of CCK in transfected COS-7 cells was detected 24, 48 and 72 h post-transfection with fluorescence microscopy and the expression level of CCK mRNA in transfected COS-7 cells was assayed by using RT-PCR. The results showed CCK pDNA was successfully constructed and expressed transiently in COS-7 cells. Green fluorescent protein could be detected in the COS-7 cells transfected with porcine CCK pDNA 24 h post-transfection. At 48th h post-transfection, the number of positive cells was increased significantly and much brighter green fluorescence could be detected. And 72 h post-transfection, the green fluorescence of positive cells became even stronger, while no green fluorescence was detected in the control group. The expression of CCK mRNA in the cells was detectable by using RT-PCR. In COS-7 cells transfected with CCK pDNA a high level of porcine CCK mRNA was detected while no expression of porcine CCKmRNA was found in the cells transfected with null plasmid. It was concluded CCK pDNA was expressed successfully in COS-7 cells, which lays a foundation for further research on the relationship between CCK and tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641841     DOI: 10.1007/s11596-007-0315-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Pancreatic cancer: 1998 update.

Authors:  C J Yeo
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

Review 2.  Gene vaccination: plasmid DNA is more than just a blueprint.

Authors:  H Tighe; M Corr; M Roman; E Raz
Journal:  Immunol Today       Date:  1998-02

3.  The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33.

Authors:  J F Rehfeld; G Sun; T Christensen; J G Hillingsø
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

4.  Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.

Authors:  Philip J Bergman; Joanne McKnight; Andrew Novosad; Sarah Charney; John Farrelly; Diane Craft; Michelle Wulderk; Yusuf Jeffers; Michel Sadelain; Ann E Hohenhaus; Neil Segal; Polly Gregor; Manuel Engelhorn; Isabelle Riviere; Alan N Houghton; Jedd D Wolchok
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

5.  Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines.

Authors:  M Hirata; M Itoh; A Tsuchida; H Ooishi; K Hanada; G Kajiyama
Journal:  FEBS Lett       Date:  1996-04-01       Impact factor: 4.124

Review 6.  Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules.

Authors:  Yu-Quan Wei
Journal:  Anticancer Drugs       Date:  2002-03       Impact factor: 2.248

7.  Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway.

Authors:  M Hirata; A Tsuchida; T Iwao; T Sasaki; K Matsubara; S Yamamoto; K Morinaka; Y Kawasaki; Y Fujimoto; H Inoue; K Kariya; G Kajiyama
Journal:  Int J Oncol       Date:  1999-06       Impact factor: 5.650

8.  Tumor immunity and autoimmunity induced by immunization with homologous DNA.

Authors:  L W Weber; W B Bowne; J D Wolchok; R Srinivasan; J Qin; Y Moroi; R Clynes; P Song; J J Lewis; A N Houghton
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

Review 9.  Gastrins, cholecystokinins and gastrointestinal cancer.

Authors:  Ahmad Aly; Arthur Shulkes; Graham S Baldwin
Journal:  Biochim Biophys Acta       Date:  2004-07-06

Review 10.  Epidemiology of pancreatic cancer.

Authors:  D S Michaud
Journal:  Minerva Chir       Date:  2004-04       Impact factor: 1.000

  10 in total
  1 in total

1.  Effect of Salvia miltiorrhiza pretreatment on the CCK and VIP expression in hepatic ischemia-reperfusion-induced digestive tract congestion.

Authors:  Zhi-Yong Zhang; Xiao-Ping Chen; Qi-Ping Lu
Journal:  Front Med China       Date:  2010-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.